Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of TAC-202 (bilastine) Under Fed and Fasted Conditions
jRCT2080222717Phase 1
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of bilastine in allergy (2 arms), sponsored by Taiho Pharmaceutical Co., Ltd. Primary endpoint: Primary pharmacokinetic parameters of bilastine under fed and fasted conditions.
02
Drugs
bilastine
03
Conditions
allergy
Beyond the preview
Go deeper on jRCT2080222717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222717.